We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » PBMs Dodge Bullet in New CMS Rule—But Remain in Washington’s Crosshairs
PBMs Dodge Bullet in New CMS Rule—But Remain in Washington’s Crosshairs
Pharmacy benefits managers breathed a sigh of relief last week when the Trump administration backed off proposals that would set Medicare drug prices based on the discounts offered by the benefits managers.